Cargando…
COVID-19 inflammation and implications in drug delivery
Growing evidence indicates that hyperinflammatory syndrome and cytokine storm observed in COVID-19 severe cases are narrowly associated with the disease’s poor prognosis. Therefore, targeting the inflammatory pathways seems to be a rational therapeutic strategy against COVID-19. Many anti-inflammato...
Autores principales: | Zoulikha, Makhloufi, Huang, Feifei, Wu, Zhenfeng, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045711/ https://www.ncbi.nlm.nih.gov/pubmed/35469984 http://dx.doi.org/10.1016/j.jconrel.2022.04.027 |
Ejemplares similares
-
Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation
por: Yang, Yi, et al.
Publicado: (2023) -
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
por: Zoulikha, Makhloufi, et al.
Publicado: (2022) -
Biological drug and drug delivery-mediated immunotherapy
por: Xiao, Qingqing, et al.
Publicado: (2021) -
Drug Delivery Implants in the Treatment of Vitreous Inflammation
por: Wang, Jillian, et al.
Publicado: (2013) -
Assessment of Algeria's electricity power demands during COVID-19 pandemic and wildfires incidents
por: Makhloufi, S., et al.
Publicado: (2022)